30 haemorrhagic strokes will take some time.
There were only 5 documented haemorrhagic strokes in the interim Stage 2 analysis that was published.
- Forums
- ASX - By Stock
- EMV
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
EMV
emvision medical devices ltd
Add to My Watchlist
0.00%
!
$1.75

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.75 |
Change
0.000(0.00%) |
Mkt cap ! $149.6M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 118 | $1.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 10015 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4118 | 1.725 |
1 | 132 | 1.720 |
1 | 118 | 1.715 |
2 | 3300 | 1.705 |
7 | 24848 | 1.700 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 10015 | 1 |
1.795 | 3600 | 1 |
1.800 | 6575 | 2 |
1.810 | 1350 | 1 |
1.840 | 3000 | 1 |
Last trade - 10.31am 04/07/2025 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online